TrialThorax2015

Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with moderate-to-severe COPD (QUANTIFY): a randomised, non-inferiority study.

Roland Buhl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.